Saman Pharmaceutical Company aims to supply the pharmaceutical needs of the country and export it to the target markets by producing various injection and washing solutions in the form of vials, bottles and multi-layer polyolefin bags in volumes of 5 to 5000 milliliters in 1363 under the name of Saman Pharmaceuticals. Receipt registration. With the efforts of local experts, despite the difficulties of the sacred defense period in 1371, this company succeeded in obtaining a license to produce 22 types of pharmaceutical products. Saman Pharmaceutical Company is built on a land of 10 hectares with an infrastructure of more than 38,000 square meters, and currently Astan Quds Razavi is one of the major shareholders of the company. In order to satisfy the stakeholders, this company has always tried to increase the quantity and quality of the products, add new products (the first in the country) to the company’s pharmaceutical products portfolio and provide appropriate services, promoting the brand of Saman Pharmaceuticals and more importantly the prestigious brand of Astan Quds. It is Razavi and in the national arena, it responds to the needs of the country’s medical community.
By implementing the principles of GMP, quality control (QC) and quality assurance (QA), Saman Pharmaceutical Company has taken steps towards the establishment of the latest global pharmaceutical standards and has used the world’s best technology in the field of injectable products. The company group has started a rapid movement towards the culture of quality management principles (QM) and in 2009, it obtained a license to establish an accredited laboratory. Also, in order to enter the international drug markets and improve the quality management system, this company has received the international standards of Pharma GMP, IQ.net and ISO 9001:2008 from the German company DQS.
In 2019, by redefining its mission and vision, this company has expanded the scope of its activities to fields such as pharmaceutical supplies, medical equipment and the production of other drugs. Accordingly, the main goal of the company is to implement GMP compliant standards, which means maintaining organizational orderliness and at the same time creating good space, infrastructure and facilities for quality production and maintenance at the level of updated national and international standards. Saman Pharmaceuticals is the first producer of recombinant biological drugs and the only exclusive producer of peritoneal dialysis solutions and a provider of special care services for kidney patients (ESRD) in Iran.
The company is committed to continuous improvement and moving in the path of excellence, and in this regard, it regularly revises its strategies, processes and organizational chart.
In 2019, by redefining its mission and vision, this company has expanded the scope of the company’s activities to areas such as pharmaceutical supplies and medical equipment and the production of other drugs. Accordingly, the main goal of the company is to implement GXP-compliant standards, which means maintaining organizational order and at the same time creating good space, infrastructure and facilities for quality production and maintenance at the level of updated national and international standards.
The company considers itself committed to continuous improvement and moving in the path of excellence, and in this regard, it regularly revises its strategies, processes and organizational chart. The motto of the year and resistance economy is:
Website design and SEO by
Samen Pharmaceutical
